Medical Devices in Diabetes

Will SGLT2-inhibitors change the landscape?

Innate immunity in pancreatic islet inflammation

The artificial beta cell. When will the dream become reality?

Observational study of insulin pump treatment

The evidence for metformin is unclear?

The ORIGIN Study And Legacy Effects

Recent studies and future research directions

EASD on insulin pump safety concerns

Elements of personalized treatment in diabetes

Novelties in neuropathy?

EASD: Rapidly changing landscape of T2DM treatment

Fix combinations in type 2 diabetes mellitus

EASD: Role of EASD and PGEC in knowledge transfer

Second line treatment of type 2 diabetes mellitus

From incretin based therapies to SGLT2 inhibitors - individualized treatment of T2DM

EASD: Therapeutic and diagnostic novelties of 2014